Nested Therapeutics is a clinical-stage biotechnology company founded in 2021 and headquartered at 1030 Massachusetts Avenue in Cambridge, Massachusetts. It discovers and develops novel, targeted, small-molecule precision medicines for patients with cancers driven by the RAS-MAPK pathway, using mutation clusters to identify druggable pockets that conventional target discovery misses. Its lead program, NST-628, is a pan-RAF/MEK non-degrading molecular glue cleared by the FDA for investigation in advanced solid tumors carrying RAS-MAPK genetic alterations. The company was launched with $125 million in financing from Versant Ventures and the life sciences investment division of Goldman Sachs Asset Management. Nested Therapeutics is a therapeutics developer, not a software vendor: it publishes a two-page marketing website and press-release PDFs, and operates no public API, developer portal, SDK or machine-readable contract of any kind.
Nested Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Precision Medicine.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: nested-therapeutics
name: Nested Therapeutics
description: 'Nested Therapeutics is a clinical-stage biotechnology company founded in 2021 and headquartered at 1030 Massachusetts
Avenue in Cambridge, Massachusetts. It discovers and develops novel, targeted, small-molecule precision medicines for patients
with cancers driven by the RAS-MAPK pathway, using mutation clusters to identify druggable pockets that conventional target
discovery misses. Its lead program, NST-628, is a pan-RAF/MEK non-degrading molecular glue cleared by the FDA for investigation
in advanced solid tumors carrying RAS-MAPK genetic alterations. The company was launched with $125 million in financing
from Versant Ventures and the life sciences investment division of Goldman Sachs Asset Management. Nested Therapeutics is
a therapeutics developer, not a software vendor: it publishes a two-page marketing website and press-release PDFs, and operates
no public API, developer portal, SDK or machine-readable contract of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/nested-therapeutics/refs/heads/main/apis.yml
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://nestedtx.com/wp-content/uploads/2022/05/nested-logo.svg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Precision Medicine
- Drug Discovery
- Life Sciences
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/nested-therapeutics-domain-security.yml
- type: Website
url: https://nestedtx.com/
- type: Careers
url: https://nestedtx.com/careers/
- type: LinkedIn
url: https://www.linkedin.com/company/nestedtx
- type: Twitter
url: https://x.com/nestedtx
x-enrichment:
date: '2026-08-26'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: Nested Therapeutics is a clinical-stage oncology drug developer whose entire public web presence is a two-page WordPress
site (home and careers, per its own sitemap.xml) plus press-release PDFs; there is no developer section, and every contract-discovery
probe against nestedtx.com — /openapi.json, /swagger.json, /api-docs, /graphql, /llms.txt, /developers and the full /.well-known/
set — returned 404, leaving only WordPress core's default /wp-json CMS endpoint, which is boilerplate rather than a published
API product.
evidence:
- url: https://nestedtx.com/openapi.json
status: 404
- url: https://nestedtx.com/developers
status: 404
- url: https://nestedtx.com/.well-known/agent-card.json
status: 404
- url: https://nestedtx.com/llms.txt
status: 404
- url: https://nestedtx.com/sitemap.xml
status: 200
checked: '2026-08-26'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →